However, the use of drugs in clinical trials markedly differs from that of the routine clinical practice in several aspects, thus limiting the generalization of results 24. In this sense, real world, non-interventional studies may provide complementary information on the effectiveness of specific treatments in real clinical practice settings 25. With pregabalin losing its patent in 2015 and less expensive generics beginning to be available in different countries, the overall consumption of gabapentinoids could increase further. A number of regulatory bodies have started to alter their approach towards the control of gabapentinoids, including a change in legal scheduling, change of treatment guidelines and labelling requirements45,48,49,50. Results from the current study, particularly in lower-middle-income and upper-middle-income countries, should be used to support plans for future national, regional, and global public health policies.
- The multinational and regional consumption levels were computed by pooling the estimates from individual countries using a random-effects model67.
- Patients, family members, or caregivers should call the doctor right away if they notice suicidal thoughts or actions, thoughts of self-harm, or any unusual changes in mood or behavior.
- This allowed the utilization of complementary data and ensured a comprehensive evaluation of the available results without incurring unnecessary redundancy.
What may interact with this medication?
At the same time, in France, about half of those who abuse pregabalin purchase it with a genuine prescription, which confirms the growing availability of the substance. There are also reports of the substance being available on the black market 51. There have also been reports of visual hallucinations 55 and lucid dreaming 56 under the influence of pregabalin, which may be of interest to psychonauts 57. Pregabalin ranked tenth in global sales and Pfizer became the largest pharmaceutical pregabalin in usa company in terms of total sales in the 2017 46.
Model Parameters
Patient pain was assumed to be intractable to therapies for underlying conditions. Compared to gabapentin, pregabalin was projected to result in 6 and 9 additional days with no or mild pain, and 0.005 and 0.009 quality-adjusted life years (QALYs), for patients with DPN and PHN, respectively. The adapted Canadian model utilized a global perspective to facilitate future adaptations to the healthcare perspectives of additional countries. The question of whether it is appropriate to restrict the circulation of pregabalin remains open. Researchers from around the world emphasise the need for pharmacists to comply with dispensing regulations as a method of reducing the prevalence of its recreational use 100.